Moreover, the results of Fig. 2A-C showed that ZIF-DHA agents could be abundantly taken up by ovarian cancer cells, characterized by a significant increase in intracellular red fluorescence (ZIF-DHA-MR was labeled by red fluorescein as described in methods). The gene discussed is NR3C2; the disease is ovarian carcinoma.